RedHill Biopharma (RDHL) Cash & Current Investments (2011 - 2026)
RedHill Biopharma (RDHL) posted Cash & Current Investments of $5.16 million for the quarter ended Jun 30, 2026, down 96.9% from $164.62 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Cash & Current Investments (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma's Cash & Current Investments came in at $3.97 million, down 14.0% from the prior year.
- Annual Cash & Current Investments has declined for four consecutive years, with a five-year compound annual growth rate of -33.0% (years ended Dec 2020 to Dec 2025).
- In prior years, RedHill Biopharma's Cash & Current Investments was $4.62 million in the year ended Dec 31, 2024 (-76.9%), $19.97 million in the year ended Dec 31, 2023 (-32.3%), $29.49 million in the year ended Dec 31, 2022 (-22.4%) and $38 million in the year ended Dec 31, 2021 (+29.7%).
- Quarterly Cash & Current Investments has run from a low of $3.97 million in the quarter ended Dec 31, 2025 to a high of $164.62 million in the quarter ended Jun 30, 2025 over five years.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was the quarter ended Dec 31, 2021, with growth of 29.7%; the weakest was the quarter ended Jun 30, 2026, with a decline of 96.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | RedHill Biopharma | 1.32 Mn | -15.30 Mn | - | 5.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.16 Mn |
| Dec 31, 2025 | 3.97 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Jun 30, 2024 | 7.28 Mn |
| Dec 31, 2023 | 5.57 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 17.57 Mn |
| Dec 31, 2022 | 19.97 Mn |
| Sep 30, 2022 | 15.20 Mn |
| Jun 30, 2022 | 26.99 Mn |
| Mar 31, 2022 | 28.85 Mn |
| Dec 31, 2021 | 29.47 Mn |
| Sep 30, 2021 | 23.25 Mn |
| Jun 30, 2021 | 51.82 Mn |
| Mar 31, 2021 | 75.97 Mn |
| Dec 31, 2020 | 29.30 Mn |
| Sep 30, 2020 | 26.20 Mn |
| Jun 30, 2020 | 22.27 Mn |
| Mar 31, 2020 | 81.61 Mn |
API Access
RedHill Biopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();